Older men with fementia are at greater risk than women of serious events after initiating antipsychotic therapy

Journal of the American Geriatrics Society

Volumn 61, Issue 1, 2013, Pages 55-61

  Rochon, Paula A ^a,b,c,d   Gruneir, Andrea ^a,c,d   Gill, Sudeep S ^d,e,f   Wu, Wei ^a   Fischer, Hadas D ^d   Bronskill, Susan E ^b,d   Normand, Sharon Lise T ^h,i   Austin, Peter C ^c,d,g   Seitz, Dallas P ^f   Bell, Chaim M ^b,c,d,j   Fu, Longdi ^d   Lipscombe, Lorraine ^a,b,c,d   Anderson, Geoffrey M ^a,c,d   Gurwitz, Jerry H ^k  

^a WOMEN S COLLEGE HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^e St Mary's of the Lake Hospital   (Canada)

^f QUEEN S UNIVERSITY   (Canada)

^g UNIVERSITY OF TORONTO   (Canada)

^h HARVARD MEDICAL SCHOOL   (United States)

ⁱ HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^j MOUNT SINAI HOSPITAL   (Canada)

^k UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

more..

Author keywords

atypical antipsychotic; dementia; older adults; serious event; sex and gender

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; OLANZAPINE; QUETIAPINE; RISPERIDONE; NEUROLEPTIC AGENT;

AGE; AGED; ARTICLE; CHARLSON COMORBIDITY INDEX; DEATH; DEMENTIA; DOSE RESPONSE; DRUG MEGADOSE; FEMALE; FOLLOW UP; HEALTH CARE FACILITY; HOSPITAL ADMISSION; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; PATIENT CARE; RISK ASSESSMENT; SEX DIFFERENCE; SIDE EFFECT; CANADA; COMPARATIVE STUDY; CONFIDENCE INTERVAL; EMERGENCY; HOSPITALIZATION; MULTICENTER STUDY; RETROSPECTIVE STUDY; RISK; RISK FACTOR; STATISTICS;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANTIPSYCHOTIC AGENTS; CONFIDENCE INTERVALS; DEMENTIA; EMERGENCIES; FEMALE; FOLLOW-UP STUDIES; HOSPITALIZATION; HUMANS; MALE; ODDS RATIO; ONTARIO; RETROSPECTIVE STUDIES; RISK FACTORS;

MLCS; MLOWN;

EID: 84872261973     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/jgs.12061     Document Type: Article

References (25)

1. Miller MA,. Gender-based differences in the toxicity of pharmaceuticals-the Food and Drug Administration's perspective. Int J Toxicol 2001; 20: 149-152.
2. Ebert SN, Liu XK, Woosley RL,. Female gender as a risk factor for drug-induced cardiac arrhythmias: Evaluation of clinical and experimental evidence. J Womens Health 1998; 7: 547-557.
3. Gurwitz JH,. The age/gender interface in geriatric pharmacotherapy. J Womens Health (Larchmt) 2005; 14: 68-72.
4. Kando JC, Yonkers KA, Cole JO,. Gender as a risk factor for adverse events to medications. Drugs 1995; 50: 1-6.
5. Martin RM, Biswas PN, Freemantle SN, et al. Age and sex distribution of suspected adverse drug reactions to newly marketed drugs in general practice in England: Analysis of 48 cohort studies. Br J Clin Pharmacol 1998; 46: 505-511.
6. United States General Accounting Office. Drug Safety: Most Drugs Withdrawn in Recent Years Had Greater Health Risks for Women. GAO-01-286R. Washington, DC: United States General Accounting Office, 2001.
7. Canadian Study of Health and Aging Working Group,. Canadian Study of Health and Aging: Study methods and prevalence of dementia. Can Med Assoc J 1994; 150: 899-913.
8. Rochon PA, Normand SL, Gomes T, et al. Antipsychotic therapy and short-term serious events in older adults with dementia. Arch Intern Med 2008; 168: 1090-1096.
9. Institute for Clinical Evaluative Sciences. Aging in Ontario: An ICES Chartbook of Health Service Use by Older Adults. Toronto, Ontario, Canada: Institute for Clinical Evaluative Sciences, 2010.
10. Gill SS, Bronskill SE, Normand SL, et al. Antipsychotic drug use and mortality in older adults with dementia. Ann Intern Med 2007; 146: 775-786.
11. Bronskill SE, Gill SS, Paterson JM, et al. Exploring variation in rates of polypharmacy across long-term care homes. J Am Med Dir Assoc 2012; 13:309. e15-e21
12. von Elm E, Altman DG, Egger M, et al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies. BMJ 2007; 335: 806-808.
13. Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 2005; 43 (11): 1130-1139.
14. Deyo RA, Cherkin DC, Ciol MA,. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992; 45: 613-619.
15. Schneeweiss S, Seeger JD, Maclure M, et al. Performance of comorbidity scores to control for confounding in epidemiologic studies using claims data. Am J Epidemiol 2001; 154: 854-864.
16. Rochon PA, Stukel TA, Sykora K, et al. Atypical antipsychotics and parkinsonism. Arch Intern Med 2005; 165: 1882-1888.
17. Centers for Medicare and Medicaid Services. State Operations Manual Appendix. Baltimore, MD: Centers for Medicare and Medicaid Services, 2011.
18. Mamdani M, Sykora K, Li P, et al. Reader's guide to critical appraisal of cohort studies: 2. Assessing potential for confounding. BMJ 2005; 330: 960-962.
19. Normand SL, Sykora K, Li P, et al. Readers guide to critical appraisal of cohort studies: 3. Analytical strategies to reduce confounding. BMJ 2005; 330: 1021-1023.
20. Statistics Canada. Life Expectancy, Abridged Life Table, at Birth and at Age 65, by Sex, Canada, Provinces and Territories, Annual (Years). Ottawa, Canada: Statistics Canada, 2005 [on-line]. Available at http://www.statcan.gc. ca/pub/82–221-x/00604/status-etat/4062645-eng.htm Accessed January 12, 2012.
21. Arias E,. United States life tables, 2007. Natl Vital Stat Rep 2011; 28:59: 1-60.
22. Smith D,. The Older Population in the United States: March 2002. Washington, DC: U.S. Census Bureau Current Population Reports, 2003.
23. Crimmins E, Kim JK, Hagedorn A,. Life with and without disease: Women experience more of both. J Women Aging 2002; 14: 47-59.
24. Ott BR, Lapane KL, Gambassi G,. Gender differences in the treatment of behavior problems in Alzheimer's disease. SAGE Study Group. Systemic assessment of geriatric drug use via epidemiology. Neurology 2000; 54: 427-432.
25. Rochon PA, Katz JN, Morrow LA, et al. Comorbid illness is associated with survival and length of hospital stay in patients with chronic disability. A prospective comparison of three comorbidity indices. Med Care 1996; 34: 1093-1101.